486 related articles for article (PubMed ID: 29233023)
21. Harnessing Polypharmacology with Computer-Aided Drug Design and Systems Biology.
Wathieu H; Issa NT; Byers SW; Dakshanamurthy S
Curr Pharm Des; 2016; 22(21):3097-108. PubMed ID: 26907947
[TBL] [Abstract][Full Text] [Related]
22. In Silico Oncology Drug Repositioning and Polypharmacology.
Cheng F
Methods Mol Biol; 2019; 1878():243-261. PubMed ID: 30378081
[TBL] [Abstract][Full Text] [Related]
23. Predicting targeted polypharmacology for drug repositioning and multi- target drug discovery.
Liu X; Zhu F; Ma XH; Shi Z; Yang SY; Wei YQ; Chen YZ
Curr Med Chem; 2013; 20(13):1646-61. PubMed ID: 23410165
[TBL] [Abstract][Full Text] [Related]
24. Transcriptome inference and systems approaches to polypharmacology and drug discovery in herbal medicine.
Li P; Chen J; Zhang W; Fu B; Wang W
J Ethnopharmacol; 2017 Jan; 195():127-136. PubMed ID: 27894972
[TBL] [Abstract][Full Text] [Related]
25. Compound promiscuity: what can we learn from current data?
Hu Y; Bajorath J
Drug Discov Today; 2013 Jul; 18(13-14):644-50. PubMed ID: 23524195
[TBL] [Abstract][Full Text] [Related]
26. Novel computational approaches to polypharmacology as a means to define responses to individual drugs.
Xie L; Xie L; Kinnings SL; Bourne PE
Annu Rev Pharmacol Toxicol; 2012; 52():361-79. PubMed ID: 22017683
[TBL] [Abstract][Full Text] [Related]
27. Network pharmacology strategies toward multi-target anticancer therapies: from computational models to experimental design principles.
Tang J; Aittokallio T
Curr Pharm Des; 2014; 20(1):23-36. PubMed ID: 23530504
[TBL] [Abstract][Full Text] [Related]
28. Modeling Polypharmacological Profiles by Affinity Fingerprinting.
Peragovics A; Simon Z; Malnasi-Csizmadia A; Bender A
Curr Pharm Des; 2016; 22(46):6885-6894. PubMed ID: 27587199
[TBL] [Abstract][Full Text] [Related]
29. Polypharmacology: The science of multi-targeting molecules.
Kabir A; Muth A
Pharmacol Res; 2022 Feb; 176():106055. PubMed ID: 34990865
[TBL] [Abstract][Full Text] [Related]
30. Combining label-free cell phenotypic profiling with computational approaches for novel drug discovery.
Fang Y
Expert Opin Drug Discov; 2015 Apr; 10(4):331-43. PubMed ID: 25727255
[TBL] [Abstract][Full Text] [Related]
31. Rational discovery of dual-indication multi-target PDE/Kinase inhibitor for precision anti-cancer therapy using structural systems pharmacology.
Lim H; He D; Qiu Y; Krawczuk P; Sun X; Xie L
PLoS Comput Biol; 2019 Jun; 15(6):e1006619. PubMed ID: 31206508
[TBL] [Abstract][Full Text] [Related]
32. Network approaches to drug discovery.
Chandra N; Padiadpu J
Expert Opin Drug Discov; 2013 Jan; 8(1):7-20. PubMed ID: 23140510
[TBL] [Abstract][Full Text] [Related]
33. Polypharmacology - foe or friend?
Peters JU
J Med Chem; 2013 Nov; 56(22):8955-71. PubMed ID: 23919353
[TBL] [Abstract][Full Text] [Related]
34. Advances and Challenges in Computational Target Prediction.
Sydow D; Burggraaff L; Szengel A; van Vlijmen HWT; IJzerman AP; van Westen GJP; Volkamer A
J Chem Inf Model; 2019 May; 59(5):1728-1742. PubMed ID: 30817146
[TBL] [Abstract][Full Text] [Related]
35. Exploring Polypharmacology in Drug Discovery and Repurposing Using the CANDO Platform.
Chopra G; Samudrala R
Curr Pharm Des; 2016; 22(21):3109-23. PubMed ID: 27013226
[TBL] [Abstract][Full Text] [Related]
36. Molecular Docking: Shifting Paradigms in Drug Discovery.
Pinzi L; Rastelli G
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31487867
[TBL] [Abstract][Full Text] [Related]
37. Polypharmacology in Precision Oncology: Current Applications and Future Prospects.
Antolin AA; Workman P; Mestres J; Al-Lazikani B
Curr Pharm Des; 2016; 22(46):6935-6945. PubMed ID: 27669965
[TBL] [Abstract][Full Text] [Related]
38. Getting the most out of PubChem for virtual screening.
Kim S
Expert Opin Drug Discov; 2016 Sep; 11(9):843-55. PubMed ID: 27454129
[TBL] [Abstract][Full Text] [Related]
39. Coping with polypharmacology by computational medicinal chemistry.
Schneider G; Reker D; Rodrigues T; Schneider P
Chimia (Aarau); 2014 Sep; 68(9):648-53. PubMed ID: 25437786
[TBL] [Abstract][Full Text] [Related]
40. Data structures for computational compound promiscuity analysis and exemplary applications to inhibitors of the human kinome.
Miljković F; Bajorath J
J Comput Aided Mol Des; 2020 Jan; 34(1):1-10. PubMed ID: 31792884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
